2003•Acta Acadimae Qingdao UmvesitatisRequires access

A DETECTION OF PLASMA ADRENOMEDULLIN ENDOTHELIN-1, AND VON WILLEBRAND FACTOR IN PATIENTS WITH HYPERTENSION

Jian Tian

Open publisher page 0 citations

Abstract

Objective To study the relationship between the risk stratification in essential hypertension(EH) and the levels of plasma VWF, ADM and ET 1, and explore the clinic significance. Methods Eighty EH patients with different risk stratification were randomly selected for this study. The plasma VWF,ADM and ET 1 were detected and compared with 20 normal controls. Results Before treatment ,the levels of plasma VWF, ET 1, ADM increased significantly in EH group compared to that of the control group, the difference was significant ( F=6.23-17.08, q=4.27-10.43, P 0.05), and the levels of VWF, ET 1 And ADM elevated with the increase of the risk ( q=3.87-6.86, P 0.05). The levels of ADM, ET 1 and VWF were lower than that of before treatment, the difference showed great difference ( t= 3.71-20.8, P 0.05). Conclusion ADM, ET 1 and VWF are involved in the occurrence and development of essential hypertension. Proper therapy can lower the levels of ET 1, ADM and VWF.

About this research paper

What this paper is about

Objective To study the relationship between the risk stratification in essential hypertension(EH) and the levels of plasma VWF, ADM and ET 1, and explore the clinic significance. Methods Eighty EH patients with different risk stratification were randomly selected for this study. The plasma VWF,ADM and ET 1 were detected and compared with 20 normal controls. Results Before treatment ,the levels of plasma VWF, ET 1, ADM increased significantly in EH group compared to that of the control group, the difference was significant ( F=6.23-17.08, q=4.27-10.43, P 0.05), and the levels of VWF, ET 1 And ADM elevated with the increase of the risk ( q=3.87-6.86, P 0.05). The levels of ADM, ET 1 and VWF were lower than that of before treatment, the difference showed great difference ( t= 3.71-20.8, P 0.05). Conclusion ADM, ET 1 and VWF are involved in the occurrence and development of essential hypertension. Proper therapy can lower the levels of ET 1, ADM and VWF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the relationship between the risk stratification in essential hypertension(EH) and the levels of plasma VWF, ADM and ET 1, and explore the clinic significance. Methods Eighty EH patients with different risk stratification were randomly selected for this study. The plasma VWF,ADM and ET 1 were detected and compared with 20 normal controls. Results Before treatment ,the levels of plasma VWF, ET 1, ADM increased significantly in EH group compared to that of the control group, the difference was significant ( F=6.23-17.08, q=4.27-10.43, P 0.05), and the levels of VWF, ET 1 And ADM elevated with the increase of the risk ( q=3.87-6.86, P 0.05). The levels of ADM, ET 1 and VWF were lower than that of before treatment, the difference showed great difference ( t= 3.71-20.8, P 0.05). Conclusion ADM, ET 1 and VWF are involved in the occurrence and development of essential hypertension. Proper therapy can lower the levels of ET 1, ADM and VWF.

Key concepts: Adrenomedullin, Von Willebrand factor, Internal medicine, Essential hypertension, Medicine, Endothelin 1, Endocrinology, Endothelin receptor

Related papers

Back to paper searchBrowse research topicsOriginal source
A DETECTION OF PLASMA ADRENOMEDULLIN ENDOTHELIN-1, AND VON WILLEBRAND FACTOR IN PATIENTS WITH HYPERTENSION — Research Paper | ScholarLens